1.Ji, HF & Zhang, HY (2006) Theoretical evaluation of flavonoids as multipotent agents to combat Alzheimer’s disease. J Mol Struct 767, 3–9.
2.Youdim, KA & Joseph, JA (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30, 583–594.
3.Hirohata, M, Hasegawa, K, Tsutsumi-Yasuhara, S et al. (2007) The anti-amyloidogenic effect is exerted against Alzheimer’s β-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 46, 1888–1889.
4.Oteiza, PI, Erlejman, AG, Verstraeten, SV et al. (2005) Flavonoid–membrane interactions: a protective role of flavonoids at the membrane surface? Clin Dev Immunol 12, 19–25.
5.Williams, RJ, Spencer, JPE & Rice-Evans, C (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838–849.
6.Commenges, D, Scotet, V, Renaud, S et al. (2000) Intake of flavonoids and risk of dementia. Eur J Epidemiol 16, 357–363.
7.Engelhardt, MJ, Geerlings, MI, Ruitenberg, A et al. (2000) Dietary intake of antioxidants and risk of Alzheimer’s disease. JAMA 287, 3223–3229.
8.Scarmeas, N, Stern, Y, Mayeux, R et al. (2009) Mediterranean diet and mild cognitive impairment. Arch Neurol 66, 216–225.
9.Scarmeas, N, Stern, Y, Mayeux, R et al. (2006) Mediterranean diet, Alzheimer disease, and vascular mediation. Arch Neurol 63, 1709–1717.
10.Scarmeas, N, Stern, Y, Tang, MX et al. (2006) Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol 59, 912–921.
11.Ng, TP, Feng, L, Niti, M et al. (2008) Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr 88, 224–231.
12.Nurk, E, Refsum, H, Drevon, CA et al. (2009) Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr 139, 120–127.
13.Pomerleau, J, McKee, M, Lobstein, T et al. (2003) The burden of disease attributable to nutrition in Europe. Public Health Nutr 6, 453–461.
14.World Health Organization (2002) The World Health Report. Geneva: WHO.
15.Muntoni, S & Muntoni, S (2006) Epidemiological association between some dietary habits and the increasing incidence of type 1 diabetes worldwide. Ann Nutr Metab 50, 11–19.
17.McDowell, I, Xi, G, Lindsay, J et al. (2007) Mapping the connections between education and dementia. J Clin Exp Neuropsychol 29, 127–141.
18.Tang, MX, Cross, P, Andrews, H et al. (2001) Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology 56, 49–56.
19.Goldbourt, U, Schnaider-Beeri, M & Davidson, M (2007) Socioeconomic status in relationship to death of vascular disease and late-life dementia. J Neurol Sci 257, 177–181.
20.Perneczky, R, Diehl-Schmid, J, Forstl, H et al. (2007) Male gender is associated with greater cerebral hypometabolism in frontotemporal dementia: evidence for sex-related cognitive reserve. Int J Geriatr Psychiatry 22, 1135–1140.
21.Lopez, AD, Mathers, CD, Ezzati, M et al. (editors) (2006) Global Burden of Disease and Risk Factors. Washington, DC/New York, NY: The World Bank/Oxford University Press.
23.Wimo, A, Winblad, B, Aguero-Torres, H et al. (2003) The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 17, 63–67.
24.Ferri, CP, Prince, M, Brayne, C et al. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112–2117.
25.World Health Organization (2006) Core Health Indicators from World Health Statistics, WHO Statistical Information System (WHOSIS). The World Health Report, 2006 Edition. http://www3.who.int/whosis/core/core_select.cfm (accessed March 2007).
26.Fratiglioni, L, De Ronchi, D & Aguero-Torres, H (1999) Worldwide prevalence and incidence of dementia. Drugs Aging 15, 365–375.
29.Nutrient Data Laboratory, Agricultural Research Service, US Department of Agriculture (2007) USDA Database for the Flavonoid Content of Selected Foods, Release 2.1. Beltsville, MD: USDA.
30.Harnly, JM, Doherty, RF, Beecher, GR et al. (2006) Flavonoid content of US fruits, vegetables, and nuts. J Agric Food Chem 54, 9966–9977.
31.Gu, L, House, SE, Wu, X et al. (2006) Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem 54, 4057–4061.
32.Miller, KB, Stuart, DA, Smith, NL et al. (2006) Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem 54, 4062–4068.
33.Wu, X, Beecher, GR, Holden, JM et al. (2006) Concentrations of anthocyanidins in common foods in the United States and estimations of normal consumption. J Agric Food Chem 54, 4069–4075.
34.Peterson, J, Dwyer, J, Bhagwat, S et al. (2005) Major flavonoids in dry tea. J Food Compost Anal 18, 487–501.
35.Auger, C, Al-Awwadi, N, Bornet, A et al. (2004) Catechins and procyanidins in Mediterranean diets. Food Res Int 37, 233–245.
36.Arts, ICW, Hollman, PC & Kromhout, D (1999) Chocolate as a source of tea flavonoids. Lancet 354, 488.
37.Arts, ICW (1999) Chocolate contains additional flavonoids not found in tea. Lancet 354, 1825.
38.Adom, KK & Liu, RH (2006) Antioxidant activity of grains. J Agric Food Chem 50, 6182–6187.
39.Adom, KK, Sorrells, ME & Liu, RH (2005) Phytochemicals and antioxidant activity of milled fractions of different wheat varieties. J Agric Food Chem 53, 2297–2306.
40.Kamath, VG, Chandrashekar, A & Rajini, PS (2004) Antiradical properties of sorghum (Sorghum bicolor L. Moench) flour extracts. J Cereal Sci 40, 283–288.
41.Holtekjolen, AK, Kinitz, C & Knutsen, SH (2006) Flavanol and bound phenolic acid contents in different barley varieties. J Agric Food Chem 54, 2253–2260.
42.Shan, B, Cai, YZ, Sun, M et al. (2005) Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 53, 7749–7759.
46.Nutrient Data Laboratory, Agricultural Research Service, US Department of Agriculture (2004) USDA Database for the Proanthocyanidin Content of Selected Foods. Beltsville, MD: USDA.
47.Lotito, SB & Frei, B (2006) Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41, 1727–1746.
48.Heim, KE, Tagliaferro, AR & Bobilya, DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure–activity relationships. J Nutr Biochem 13, 572–584.
49.Agullo, G, Gamet-Payrastre, L, Manenti, S et al. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 1649–1657.
50.Chen, D, Daniel, KG, Chen, MS et al. (2005) Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol 69, 1421–1432.
51.Shimmyo, Y, Kihara, T, Akaike, A et al. (2008) Flavonols and flavones as BACE-1 inhibitors: structure–activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim Biophys Acta 1780, 819–825.
52.Padilla, E, Ruiz, E, Redondo, S et al. (2005) Relationship between vasodilation capacity and phenolic content of Spanish wines. Eur J Pharmacol 517, 84–91.
53.Kalkbrenner, F, Wurm, G & von Bruchhausen, F (1992) In vitro inhibition and stimulation of purified prostaglandin endoperoxide synthase by flavonoids: structure–activity relationship. Pharmacology 44, 1–12.
54.Bastianetto, S, Brouillette, J & Quirion, R (2007) Neuroprotective effects of natural products: interaction with intracellular kinases, amyloid peptides and a possible role for transthyretin. Neurochem Res 32, 1720–1725.
55.Yao, Y & Vieira, A (2007) Protective activities of Vaccinium antioxidants with potential relevance to mitochondrial dysfunction and neurotoxicity. Neurotoxicolgy 28, 93–100.
56.Hertog, MG, Feskens, EJ, Hollman, PC et al. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342, 1007–1011.
57.Hertog, MG, Feskens, EJM & Kromhout, D (1997) Antioxidant flavonols and coronary heart disease risk. Lancet 349, 699.